ID   ACTHR_HUMAN             Reviewed;         297 AA.
AC   Q01718; A8K016; Q3MI45; Q504X6;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   07-APR-2021, entry version 188.
DE   RecName: Full=Adrenocorticotropic hormone receptor;
DE            Short=ACTH receptor;
DE            Short=ACTH-R;
DE   AltName: Full=Adrenocorticotropin receptor;
DE   AltName: Full=Melanocortin receptor 2;
DE            Short=MC2-R;
GN   Name=MC2R; Synonyms=ACTHR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Skin;
RX   PubMed=1325670; DOI=10.1126/science.1325670;
RA   Mountjoy K.G., Robbins L.S., Mortrud M., Cone R.D.;
RT   "The cloning of a family of genes that encode the melanocortin receptors.";
RL   Science 257:1248-1251(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Suwa M., Sato T., Okouchi I., Arita M., Futami K., Matsumoto S.,
RA   Tsutsumi S., Aburatani H., Asai K., Akiyama Y.;
RT   "Genome-wide discovery and analysis of human seven transmembrane helix
RT   receptor genes.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Adrenal gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-293.
RX   PubMed=8463333;
RA   Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G.,
RA   Watson S.J., Delvalle J., Yamada T.;
RT   "Molecular cloning of a novel melanocortin receptor.";
RL   J. Biol. Chem. 268:8246-8250(1993).
RN   [8]
RP   INTERACTION WITH MRAP.
RX   PubMed=15654338; DOI=10.1038/ng1501;
RA   Metherell L.A., Chapple J.P., Cooray S., David A., Becker C.,
RA   Rueschendorf F., Naville D., Begeot M., Khoo B., Nuernberg P., Huebner A.,
RA   Cheetham M.E., Clark A.J.L.;
RT   "Mutations in MRAP, encoding a new interacting partner of the ACTH
RT   receptor, cause familial glucocorticoid deficiency type 2.";
RL   Nat. Genet. 37:166-170(2005).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH MRAP AND MRAP2.
RX   PubMed=19329486; DOI=10.1073/pnas.0809918106;
RA   Chan L.F., Webb T.R., Chung T.T., Meimaridou E., Cooray S.N., Guasti L.,
RA   Chapple J.P., Egertova M., Elphick M.R., Cheetham M.E., Metherell L.A.,
RA   Clark A.J.;
RT   "MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor
RT   family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:6146-6151(2009).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH MRAP AND MRAP2.
RX   PubMed=20371771; DOI=10.1126/scisignal.2000593;
RA   Sebag J.A., Hinkle P.M.;
RT   "Regulation of G protein-coupled receptor signaling: specific dominant-
RT   negative effects of melanocortin 2 receptor accessory protein 2.";
RL   Sci. Signal. 3:RA28-RA28(2010).
RN   [11]
RP   REVIEW ON GCCD1 VARIANTS.
RA   Clark A.J.L., Weber A.;
RT   "Molecular insights into inherited ACTH resistance syndromes.";
RL   Trends Endocrinol. Metab. 5:209-214(1994).
RN   [12]
RP   VARIANT GCCD1 ILE-74.
RX   PubMed=8094489; DOI=10.1016/0140-6736(93)90208-x;
RA   Clark A.J.L., McLoughlin L., Grossman A.;
RT   "Familial glucocorticoid deficiency associated with point mutation in the
RT   adrenocorticotropin receptor.";
RL   Lancet 341:461-462(1993).
RN   [13]
RP   VARIANT GCCD1 ARG-120.
RX   PubMed=8227361; DOI=10.1172/jci116853;
RA   Tsigos C., Arai K., Hung W., Chrousos G.P.;
RT   "Hereditary isolated glucocorticoid deficiency is associated with
RT   abnormalities of the adrenocorticotropin receptor gene.";
RL   J. Clin. Invest. 92:2458-2461(1993).
RN   [14]
RP   VARIANTS GCCD1 ASN-107 AND PHE-251.
RX   PubMed=8636348; DOI=10.1210/jcem.81.4.8636348;
RA   Naville D., Barjhoux L., Jaillard C., Faury D., Despert F., Esteva B.,
RA   Durand P., Saez J.M., Begeot M.;
RT   "Demonstration by transfection studies that mutations in the
RT   adrenocorticotropin receptor gene are one cause of the hereditary syndrome
RT   of glucocorticoid deficiency.";
RL   J. Clin. Endocrinol. Metab. 81:1442-1448(1996).
RN   [15]
RP   VARIANTS GCCD1 ASN-103 AND TRP-137.
RX   PubMed=10971458; DOI=10.1046/j.1365-2265.2000.01040.x;
RA   Ishii T., Ogata T., Sasaki G., Sato S., Kinoshita E.I., Matsuo N.;
RT   "Novel mutations of the ACTH receptor gene in a female adult patient with
RT   adrenal unresponsiveness to ACTH.";
RL   Clin. Endocrinol. (Oxf.) 53:389-392(2000).
RN   [16]
RP   VARIANTS GCCD1 ILE-74; TRP-137 AND CYS-254.
RX   PubMed=12213892; DOI=10.1210/jc.2002-020501;
RA   Fluck C.E., Martens J.W.M., Conte F.A., Miller W.L.;
RT   "Clinical, genetic, and functional characterization of adrenocorticotropin
RT   receptor mutations using a novel receptor assay.";
RL   J. Clin. Endocrinol. Metab. 87:4318-4323(2002).
RN   [17]
RP   VARIANT PRO-137.
RX   PubMed=20108423;
RA   Mueller O.T., Coovadia A.;
RT   "Novel human pathological mutations. Gene symbol: MC2R. Disease:
RT   Glucocorticoid deficiency.";
RL   Hum. Genet. 127:112-112(2010).
CC   -!- FUNCTION: Receptor for corticotropin (ACTH). This receptor is mediated
CC       by G proteins (G(s)) which activate adenylate cyclase (cAMP).
CC       {ECO:0000269|PubMed:19329486, ECO:0000269|PubMed:20371771}.
CC   -!- SUBUNIT: Interacts with MRAP; increasing ligand-sensitivity and
CC       generation of cAMP. Interacts with MRAP2; competing with MRAP for
CC       binding to MC2R and impairing the binding of corticotropin (ACTH).
CC       {ECO:0000269|PubMed:15654338, ECO:0000269|PubMed:19329486,
CC       ECO:0000269|PubMed:20371771}.
CC   -!- INTERACTION:
CC       Q01718; Q8TCY5: MRAP; NbExp=3; IntAct=EBI-9537171, EBI-9538727;
CC       Q01718; Q8TCY5-1: MRAP; NbExp=3; IntAct=EBI-9537171, EBI-21991233;
CC       Q01718; Q96G30: MRAP2; NbExp=2; IntAct=EBI-9537171, EBI-9537218;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Melanocytes and corticoadrenal tissue.
CC   -!- DISEASE: Glucocorticoid deficiency 1 (GCCD1) [MIM:202200]: A form of
CC       glucocorticoid deficiency, a rare autosomal recessive disorder
CC       characterized by resistance to ACTH action on the adrenal cortex,
CC       adrenal insufficiency and an inability of the adrenal cortex to produce
CC       cortisol. It usually presents in the neonatal period or in early
CC       childhood with episodes of hypoglycemia and other symptoms related to
CC       cortisol deficiency, including failure to thrive, recurrent illnesses
CC       or infections, convulsions, and shock. In a small number of patients
CC       hypoglycemia can be sufficiently severe and persistent that it leads to
CC       serious long-term neurological damage or death. The diagnosis is
CC       readily confirmed with a low plasma cortisol measurement in the
CC       presence of an elevated ACTH level, and normal aldosterone and plasma
CC       renin measurements. {ECO:0000269|PubMed:10971458,
CC       ECO:0000269|PubMed:12213892, ECO:0000269|PubMed:8094489,
CC       ECO:0000269|PubMed:8227361, ECO:0000269|PubMed:8636348}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X65633; CAA46587.1; -; Genomic_DNA.
DR   EMBL; AB065915; BAC06130.1; -; Genomic_DNA.
DR   EMBL; AK289381; BAF82070.1; -; mRNA.
DR   EMBL; AK315319; BAG37722.1; -; mRNA.
DR   EMBL; CH471113; EAX01503.1; -; Genomic_DNA.
DR   EMBL; BC069074; AAH69074.1; -; mRNA.
DR   EMBL; BC094710; AAH94710.1; -; mRNA.
DR   EMBL; BC104169; AAI04170.1; -; mRNA.
DR   EMBL; BC104170; AAI04171.1; -; mRNA.
DR   EMBL; AY225229; AAO67714.1; -; Genomic_DNA.
DR   CCDS; CCDS11869.1; -.
DR   PIR; C43265; C43265.
DR   RefSeq; NP_000520.1; NM_000529.2.
DR   RefSeq; NP_001278840.1; NM_001291911.1.
DR   RefSeq; XP_016881270.1; XM_017025781.1.
DR   SMR; Q01718; -.
DR   BioGRID; 110328; 3.
DR   DIP; DIP-29949N; -.
DR   IntAct; Q01718; 2.
DR   MINT; Q01718; -.
DR   STRING; 9606.ENSP00000333821; -.
DR   BindingDB; Q01718; -.
DR   ChEMBL; CHEMBL1965; -.
DR   DrugBank; DB11653; Bremelanotide.
DR   DrugBank; DB01285; Corticotropin.
DR   DrugBank; DB09334; Seractide acetate.
DR   DrugBank; DB01284; Tetracosactide.
DR   DrugCentral; Q01718; -.
DR   GuidetoPHARMACOLOGY; 283; -.
DR   TCDB; 9.A.14.2.4; the g-protein-coupled receptor (gpcr) family.
DR   GlyGen; Q01718; 2 sites.
DR   iPTMnet; Q01718; -.
DR   PhosphoSitePlus; Q01718; -.
DR   BioMuta; MC2R; -.
DR   DMDM; 399002; -.
DR   PaxDb; Q01718; -.
DR   PeptideAtlas; Q01718; -.
DR   PRIDE; Q01718; -.
DR   ProteomicsDB; 57983; -.
DR   Antibodypedia; 21964; 282 antibodies.
DR   Ensembl; ENST00000327606; ENSP00000333821; ENSG00000185231.
DR   GeneID; 4158; -.
DR   KEGG; hsa:4158; -.
DR   UCSC; uc002ksp.2; human.
DR   CTD; 4158; -.
DR   DisGeNET; 4158; -.
DR   GeneCards; MC2R; -.
DR   HGNC; HGNC:6930; MC2R.
DR   HPA; ENSG00000185231; Group enriched (adrenal gland, pituitary gland).
DR   MalaCards; MC2R; -.
DR   MIM; 202200; phenotype.
DR   MIM; 607397; gene.
DR   neXtProt; NX_Q01718; -.
DR   OpenTargets; ENSG00000185231; -.
DR   Orphanet; 361; Familial glucocorticoid deficiency.
DR   PharmGKB; PA30674; -.
DR   VEuPathDB; HostDB:ENSG00000185231.4; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00960000186617; -.
DR   HOGENOM; CLU_009579_13_0_1; -.
DR   InParanoid; Q01718; -.
DR   OMA; LYVYMFM; -.
DR   OrthoDB; 988552at2759; -.
DR   PhylomeDB; Q01718; -.
DR   TreeFam; TF332646; -.
DR   PathwayCommons; Q01718; -.
DR   Reactome; R-HSA-375276; Peptide ligand-binding receptors.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-5579031; Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD).
DR   Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production.
DR   SIGNOR; Q01718; -.
DR   BioGRID-ORCS; 4158; 6 hits in 983 CRISPR screens.
DR   GeneWiki; ACTH_receptor; -.
DR   GenomeRNAi; 4158; -.
DR   Pharos; Q01718; Tclin.
DR   PRO; PR:Q01718; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   RNAct; Q01718; protein.
DR   Bgee; ENSG00000185231; Expressed in adrenal tissue and 41 other tissues.
DR   ExpressionAtlas; Q01718; baseline and differential.
DR   Genevisible; Q01718; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0004978; F:corticotropin receptor activity; TAS:ProtInc.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0004977; F:melanocortin receptor activity; TAS:ProtInc.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc.
DR   GO; GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; TAS:Reactome.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0019222; P:regulation of metabolic process; IBA:GO_Central.
DR   InterPro; IPR001168; ACTH_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR001671; Melcrt_ACTH_rcpt.
DR   PANTHER; PTHR22750:SF3; PTHR22750:SF3; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00520; ACTROPHINR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00534; MCRFAMILY.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disease variant; G-protein coupled receptor; Glycoprotein;
KW   Lipoprotein; Membrane; Palmitate; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..297
FT                   /note="Adrenocorticotropic hormone receptor"
FT                   /id="PRO_0000069054"
FT   TOPO_DOM        1..23
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        24..49
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        50..58
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        59..79
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        80..104
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        105..126
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        127..147
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        148..168
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        169..180
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        181..199
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        200..217
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        218..244
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        245..256
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        257..278
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        279..297
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   LIPID           293
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        17
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         27
FT                   /note="P -> R (in dbSNP:rs28926178)"
FT                   /id="VAR_003509"
FT   VARIANT         74
FT                   /note="S -> I (in GCCD1; complete loss of activity;
FT                   dbSNP:rs104894658)"
FT                   /evidence="ECO:0000269|PubMed:12213892,
FT                   ECO:0000269|PubMed:8094489"
FT                   /id="VAR_003510"
FT   VARIANT         103
FT                   /note="D -> N (in GCCD1; dbSNP:rs768093045)"
FT                   /evidence="ECO:0000269|PubMed:10971458"
FT                   /id="VAR_010702"
FT   VARIANT         107
FT                   /note="D -> N (in GCCD1; dbSNP:rs104894661)"
FT                   /evidence="ECO:0000269|PubMed:8636348"
FT                   /id="VAR_015095"
FT   VARIANT         120
FT                   /note="S -> R (in GCCD1; dbSNP:rs104894656)"
FT                   /evidence="ECO:0000269|PubMed:8227361"
FT                   /id="VAR_003511"
FT   VARIANT         128
FT                   /note="R -> C (in GCCD1; dbSNP:rs104894657)"
FT                   /id="VAR_003512"
FT   VARIANT         137
FT                   /note="R -> P (found in a glucocorticoid deficiency patient
FT                   carrying also mutation I-74; dbSNP:rs1208417750)"
FT                   /evidence="ECO:0000269|PubMed:20108423"
FT                   /id="VAR_064986"
FT   VARIANT         137
FT                   /note="R -> W (in GCCD1; partial loss of ACTIVITY;
FT                   dbSNP:rs104894660)"
FT                   /evidence="ECO:0000269|PubMed:10971458,
FT                   ECO:0000269|PubMed:12213892"
FT                   /id="VAR_010703"
FT   VARIANT         146
FT                   /note="R -> H (in GCCD1; dbSNP:rs758709668)"
FT                   /id="VAR_003513"
FT   VARIANT         251
FT                   /note="C -> F (in GCCD1; dbSNP:rs104894662)"
FT                   /evidence="ECO:0000269|PubMed:8636348"
FT                   /id="VAR_015096"
FT   VARIANT         254
FT                   /note="Y -> C (in GCCD1; complete loss of activity;
FT                   dbSNP:rs28940892)"
FT                   /evidence="ECO:0000269|PubMed:12213892"
FT                   /id="VAR_015295"
FT   VARIANT         278
FT                   /note="F -> C (in dbSNP:rs28926182)"
FT                   /id="VAR_049369"
SQ   SEQUENCE   297 AA;  33927 MW;  66EE31961ABB8773 CRC64;
     MKHIINSYEN INNTARNNSD CPRVVLPEEI FFTISIVGVL ENLIVLLAVF KNKNLQAPMY
     FFICSLAISD MLGSLYKILE NILIILRNMG YLKPRGSFET TADDIIDSLF VLSLLGSIFS
     LSVIAADRYI TIFHALRYHS IVTMRRTVVV LTVIWTFCTG TGITMVIFSH HVPTVITFTS
     LFPLMLVFIL CLYVHMFLLA RSHTRKISTL PRANMKGAIT LTILLGVFIF CWAPFVLHVL
     LMTFCPSNPY CACYMSLFQV NGMLIMCNAV IDPFIYAFRS PELRDAFKKM IFCSRYW
//
